| Reviewer | Employment | Research Grant | Other Research Support | Speakers' Bureau/ Honoraria |
Expert Witness | Ownership Interest | Consultant/ Advisory Board |
Other |
|---|---|---|---|---|---|---|---|---|
| Alix Carter | Dalhousie University (Canada) | Maritime Heart* | None | None | None | None | None | None |
| Henry Halperin | Johns Hopkins University | Zoll Medical†; NIH† | None | None | None | None | None | None |
| Jonathan Jui | Oregon Health and Science University | NIH* | None | None | None | None | None | None |
| Fred Severyn | Denver Health and Hospital Authority and University of Colorado Anschutz Medical Campus; University of Arkansas | None | None | None | None | None | None | None |
| Robert A. Swor | William Beaumont Hospital | None | None | None | None | None | None | None |
| Andrew H. Travers | Emergency Health Services (Canada) | None | None | None | None | None | None | None |
This table represents the relationships of reviewers that may be perceived as actual or reasonably perceived conflicts of interest as reported on the Disclosure Questionnaire, which all reviewers are required to complete and submit. A relationship is considered to be “significant” if (a) the person receives $10000 or more during any 12-month period, or 5% or more of the person’s gross income; or (b) the person owns 5% or more of the voting stock or share of the entity, or owns $10000 or more of the fair market value of the entity. A relationship is considered to be “modest” if it is less than “significant” under the preceding definition.
*Modest.
†Significant